Posted by Michael Wonder on 18 Apr 2022
Switzerland approves its first protein-based Covid vaccine
15 April 2022 - Swissmedic announced its approval on Wednesday making Nuvaxovid the first protein-based vaccine to be licensed in Switzerland.
The American biotech firm Novavax had applied for approval on February 14 through Swiss partner Future Health Pharma.
